RIOX2 and COVID-19: Silencing of mdig in human lung epithelial cells was recently shown to result in downregulation of several genes, which are overexpressed in the bronchoalveolar lavage fluid (BALF) of COVID-19 patients, indicating a potential positive regulatory effect for mdig on the genes involved in the pathogenesis of COVID-19 [10].